41
Participants
Start Date
September 30, 2011
Primary Completion Date
August 31, 2013
Study Completion Date
August 30, 2013
Aprepitant
Oral aprepitant will be given to the participant on Days 1-5 of standard induction treatment. A dose of 125 mg will be given on Day 1 and 80 mg will be given on Days 2-5.
Princess Margaret Hospital, Toronto
Merck Sharp & Dohme LLC
INDUSTRY
University Health Network, Toronto
OTHER